Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Clonixin

17737-65-4C13H11ClN2O2262.696 g/mol

A pyridinemonocarboxylic acid that is nicotinic acid substituted at position 2 by a (2-methyl-3-chlorophenyl)amino group. Used (as its lysine salt) for treatment of renal colic, muscular pain and moderately severe migraine attacks. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number17737-65-4ChEBI ↗
Molecular formulaC13H11ClN2O2ChEBI ↗
Molar mass262.696 g/molChEBI ↗
Monoisotopic mass262.05091 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:76200ChEBI ↗

Cross-source molecular data

PubChem
Molar mass262.69 g/molPubChem ↗
Exact mass262.0509053 DaPubChem ↗
Computed XLogP3.8PubChem ↗
Topological polar surface area (Ų)62.2PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
clonixin
2-[(3-chloro-2-methylphenyl)amino]nicotinic acid
CLOMYZFHNHFSIQ-UHFFFAOYSA-N
Cc1c(Cl)cccc1Nc1ncccc1C(=O)O
InChI=1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)

Names & synonyms

2-[(3-chloro-2-methylphenyl)amino]nicotinic acidclonixineclonixinoclonixinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

non-steroidal anti-inflammatory drugnon-narcotic analgesicantipyreticEC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitorvasodilator agentlipoxygenase inhibitorplatelet aggregation inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00380668 mol

Uses 262.696 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 13 atoms
59.44%
Cl
Chlorine · 1 atom
13.49%
O
Oxygen · 2 atoms
12.18%
N
Nitrogen · 2 atoms
10.66%
H
Hydrogen · 11 atoms
4.22%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Lack of effect of rheumatoid arthritis on clonixin metabolism. ↗Clinical pharmacology and therapeutics · 1975 May · PMID 1092517
US2005163847 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US2008014272 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:76200

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 28718 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.